Experimental analysis shows vitamin D improves cognitive dysfunction in mice with chemotherapy-induced neurotoxicity, suggesting potential therapeutic use.
This study investigated the neuroprotective effects of vitamin D (VD) supplementation in mitigating chemotherapy-induced cognitive dysfunction (CICD) induced by doxorubicin (DOX) in a mouse model. Given the widespread impact of chemotherapy-induced neurotoxicity, the purpose was to explore the potential of VD to alleviate cognitive impairment and its underlying molecular mechanisms. We administered cholecalciferol emulsion (CCE), a VD analog, and assessed its effects on behavior, oxidative stress, inflammation, and neuronal integrity. Our findings demonstrate that CCE treatment significantly improved cognitive function, reduced oxidative stress, and attenuated neuroinflammation in the hippocampus. Furthermore, molecular analysis revealed that VD supplementation modulated the Wnt/β-catenin signaling pathway, notably through the suppression of SFRP1 and activation of PPAR-γ. These results suggest that VD exerts its neuroprotective effects by regulating key signaling pathways involved in neuroprotection, making it a promising candidate for therapeutic strategies to mitigate doxorubicin-induced cognitive decline.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: